Discovery and Characterization of a New Crustin Antimicrobial Peptide from Amphibalanus amphitrite .
Wei ZhangXiaohang XuJun ZhangTing YeQiao ZhouYing XuWenyi LiZhang-Li HuChenjing ShangPublished in: Pharmaceutics (2022)
Crustins are an antimicrobial peptide (AMP) family that plays an important role in innate immunity in crustaceans. It is important to discover new AMPs from natural sources to expand the current database. Here, we identified and characterized a new crustin family member, named Aa Crus1, from Amphibalanus amphitrite . Aa Crus1 shares high identity (48.10%) with PvCrus , a Type I crustin of Penaeus vannamei that possesses a whey acidic protein (WAP) domain. Aa Crus1 contains 237 amino acids and eight cysteine residues forming conserved 'four-disulfide core' structure. Our recombinant Aa Crus1 (r Aa Crus 1) could inhibit the growth of two Gram-positive bacteria ( Staphylococcus aureus , Bacillus sp. T2) and four Gram-negative bacteria ( Vibrio parahaemolyticus , Vibrio harveyi , Vibrio anguillarum , Vibrio alginolyticus ) with a minimum inhibitory concentration of 3.5-28 μM. It can further induce agglutination of both Gram-positive and Gram-negative bacteria. r Aa Crus1 can bind to bacteria and damage bacterial cell membranes. Furthermore, r Aa Crus1 disrupted biofilm development of S. aureus and V. parahaemolyticus . Our discovery and characterization of this new crustin can be further optimized as a good alternative to antibiotics.
Keyphrases
- biofilm formation
- staphylococcus aureus
- small molecule
- amino acid
- pseudomonas aeruginosa
- gram negative
- oxidative stress
- escherichia coli
- candida albicans
- stem cells
- cystic fibrosis
- multidrug resistant
- emergency department
- drinking water
- transcription factor
- cell therapy
- bone marrow
- electronic health record
- adverse drug
- single molecule